| ID | Name | CAS | Properties |
Tfus (K) |
| 119-503-1 |
6«beta»-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, syn
|
|
4 | 384.24 |
| 119-750-7 |
Silane, [[(3«beta»,17«beta»)-androst-5-ene-3,17-diyl]bis(oxy)]bis[dimethyl-2-propenyl-
|
66250-82-6 |
4 | 337.73 |
| 119-992-9 |
1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(trimethylsilyl)-
|
62374-32-7 |
4 | 462.56 |
| 120-552-5 |
Pregn-4-ene-3,20-dione, 11-hydroxy-17,21-bis[(trimethylsilyl)oxy]-, bis(O-methyloxime), (11«beta»)-
|
57305-44-9 |
4 | 403.25 |
| 120-855-9 |
6«alpha»-hydroxy-pregn-4-ene-3,20-dione, MO-TMS, syn
|
|
4 | 384.24 |
| 120-920-6 |
2,2-Dichloropropanoic acid compound with n,n-dimethylamine (1:1)
|
|
4 | 380.90 |
| 121-822-4 |
1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-
|
|
4 | 593.77 |
| 122-219-3 |
3-Hydroxy-4-methoxybenzoic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
4 | 364.30 |
| 122-879-1 |
Trimethylsilyl 4-(2-aminophenyl)-4-oxo-2-[(trimethylsilyl)amino]butanoate
|
|
4 | 351.13 |
| 123-526-1 |
5-Pregnene-3«beta»,20«beta»,21-triol, methylboronate-TMS
|
|
4 | 382.63 |
| 123-652-1 |
3H-1,4-benzodiazepine-2,5-dione, 8-chloro-1,2,4,5-tetrahydro-1,4-dimethyl-
|
1018-73-1 |
4 | 404.69 |
| 123-693-6 |
2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-3-[(trimethylsilyl)oxy]-
|
35147-95-6 |
4 | 389.17 |
| 123-962-7 |
Silane, [[(3«beta»,17«beta»)-androst-5-ene-3,17-diyl]bis(oxy)]bis[(1,1-dimethylethyl)dimethyl-
|
42151-22-4 |
4 | 378.70 |
| 124-812-2 |
Ketone, 5-amino-4-nitro-2-thienyl-3,4-dichlorophenyl
|
|
4 | 485.39 |
| 11-734-4 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, TMS
|
|
3 | 360.81 |
| 12-155-6 |
3,3-Dimethyl-1-(4-phenylphenoxy)-1-(1,2,4-triazol-1-yl)butan-2-ol, trimethylsilyl ether
|
|
3 | 380.94 |
| 13-180-7 |
5«alpha»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | 363.33 |
| 13-232-9 |
tert-Butyldimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 362.85 |
| 13-482-2 |
3.alpha.,5.beta.-dihydroxy-5.beta.-cholan-24-oic acid, TMS
|
|
3 | 362.57 |
| 13-690-1 |
5-Cholenoic acid, 3-«beta»,12-«alpha»-dihydroxy, methyl ester, TMS
|
|
3 | 365.22 |
| 13-761-2 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one-O-methyloxime, triimethylsilyl
|
|
3 | 380.14 |
| 13-818-9 |
5«beta»-cholestane, 3«alpha»,7«beta»,12«alpha»-trihydroxy, TMS
|
|
3 | 353.42 |
| 14-269-8 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi
|
|
3 | 421.39 |
| 14-306-6 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi, (20-O)-TMSi
|
|
3 | 381.62 |
| 14-864-7 |
Silane, [(3«beta»)-cholesta-5,7-dien-3-yloxy]trimethyl-
|
2625-44-7 |
3 | 357.69 |
| 15-054-5 |
[1,2,4]Triazolo[1,5-a]pyrimidin-7-ol, 5-methyl-
|
2503-56-2 |
3 | 556.15 |
| 15-373-1 |
1H-Naphtho[2,1-b]pyran-1-one, 3-phenyl-
|
6051-87-2 |
3 | 437.15 |
| 16-398-3 |
1H-pyrido[3,4-b]indole-3-carboxylic acid, 2,3,4,9-tetrahydro-
|
|
3 | 569.15 |
| 16-756-5 |
5«beta»-Homocholane-3«alpha»,7«alpha»,25-triol, TMS
|
|
3 | 363.13 |
| 17-014-7 |
epi-5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 361.90 |
| 18-481-8 |
Benzeneacetic acid, «alpha»-hydroxy-«alpha»-phenyl-, 1-methyl-3-piperidinyl ester
|
3321-80-0 |
3 | 365.86 |
| 18-772-5 |
Benzenamine, N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]-2-thiazolidinylidene]-
|
37893-02-0 |
3 | 391.15 |
| 19-562-7 |
1,3,5(10)-Oestratriene-2,3,17.beta.-triol, 2,3-TMS-17-HFB
|
|
3 | 388.46 |
| 19-671-6 |
1,3,5(10)-Oestratriene-2-methoxy-3,17«beta»-diol, 3-TBDMS-17-HFB
|
|
3 | 389.26 |
| 21-300-4 |
Phosphoric acid, 2-(diethylamino)-6-methyl-4-pyrimidinyl diethyl ester
|
|
3 | 288.45 |
| 22-124-9 |
1,1'-Bis[n-methyl-n-(4-nitrophenyl)-carboxamido] ferrocene
|
|
3 | 459.46 |
| 25-289-4 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»-ol (stigmastanol), DMESI
|
|
3 | 352.33 |
| 26-737-5 |
5«alpha»-Pregnane-3«alpha»,20«alpha»,21-triol, TMS
|
|
3 | 363.02 |
| 27-970-5 |
5-«beta»-Pregnan-20-«alpha»-ol-3-one, MO-TMS
|
|
3 | 378.57 |
| 28-380-9 |
5-«alpha»-Androstan-3-«alpha»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 396.41 |
| 28-753-5 |
5-«alpha»-Pregnan-3-«alpha»-16-«alpha»-diol-20-one, TMS
|
|
3 | 394.41 |
| 29-886-7 |
5-«beta»-Cholestan-3-«beta»,7-«alpha»,12-«alpha»-triol, TMS
|
|
3 | 353.42 |
| 31-960-1 |
2-(2,4-Dichlorophenyl)-1-(1,2,4-triazol-1-yl)hexan-2-ol, trimethylsilyl ether
|
|
3 | 310.68 |
| 32-242-7 |
2,4,6(1H,3h,5h)-pyrimidinetrione, 5-phenyl-1-(phenylmethyl)-
|
|
3 | 437.15 |
| 32-527-1 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol, bis(trimethylsilyl) ether
|
10426-36-5 |
3 | 363.33 |
| 34-872-6 |
Methyl 5-«beta»-cholan-3-«beta»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 378.17 |
| 35-400-8 |
5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 368.19 |
| 35-938-2 |
5«alpha»-Pregnane-3«beta», 20«beta», 21-triol, MO TMS
|
|
3 | 363.02 |
| 36-250-4 |
epi-5«beta»-Campestanol (24«alpha»-methyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 368.19 |
| 36-761-7 |
5-Pregnen-3-«alpha»,20-«alpha»-diol-20-GlcNAc TMS
|
|
3 | 406.20 |
| 37-683-3 |
5-«beta»-Pregnan-3-«alpha»-ol-20-one, MO-TMS
|
|
3 | 380.14 |
| 38-365-5 |
5-(3-Dimethylaminopropyl)-10,11-dihydro-5h-dibenz-[b,f]-azepine, hydrochloride
|
|
3 | 445.10 |
| 38-420-3 |
Silane, [(3,7,11,15-tetramethyl-2-hexadecenyl)oxy]trimethyl-
|
57397-39-4 |
3 | 217.54 |
| 38-562-6 |
Androstane, 3,17-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»,17«alpha»)-
|
10426-35-4 |
3 | 363.33 |
| 38-861-4 |
5-«alpha»-Pregnan-3-«beta»-16-«alpha»-diol-20-one, TMS
|
|
3 | 394.41 |
| 39-634-5 |
5-«alpha»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 378.57 |
| 39-730-8 |
5-«beta»-Pregnan-20-«beta»-ol-3-one, MO-TMS
|
|
3 | 378.57 |
| 41-865-6 |
5-«alpha»-Pregnan-3-«beta»,20-«alpha»,21-triol, TMS
|
|
3 | 363.02 |
| 42-635-0 |
5«beta»-Pregnane-3«beta»-ol-20-one, MO TMS
|
|
3 | 380.14 |
| 43-713-2 |
Methyl 5-«beta»-cholan-3-«alpha»-ol-12-one-24-oate, oxime, TMS
|
|
3 | 378.17 |
| 44-687-1 |
Phenothiazine, 2-chloro-10-(3-dimethylaminopropyl)-, cmpd with o-(p-hydroxybenzoyl)benzoic acid (1 to 1)
|
|
3 | 521.95 |
| 44-863-5 |
Silane, [(3.beta.,5.alpha.)-cholest-7-en-3-yloxy]trimethyl-
|
|
3 | 363.55 |
| 45-247-8 |
Silane, trimethyl[[(3«beta»,5«alpha»)-stigmastan-3-yl]oxy]-
|
55493-85-1 |
3 | 361.90 |
| 46-896-7 |
5-«alpha»-Pregnan-3-«beta»,15 or 16-diol-20-one, MeTMS
|
|
3 | 394.41 |
| 47-555-4 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol,bis-TMS
|
|
3 | 363.33 |
| 50-920-4 |
Ergosta-5,7,9(11),22-tetraen-3«beta»-ol, TMS
|
|
3 | 393.63 |
| 51-206-6 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»,21-triol, MeTMS
|
|
3 | 363.02 |
| 51-590-0 |
1-Cyclopentadienyl-5-phenyl-1,1,3,3,5,5-hexamethyl trisiloxane
|
|
3 | 273.55 |
| 51-610-7 |
5-Cholesten-3-«beta»,7-«alpha»,25,26-tetrol, TMS
|
|
3 | 353.70 |
| 53-148-9 |
2H-Pyrido[3,2,b]-1,4-oxazin-3[4H]-one
|
|
3 | 479.15 |
| 53-221-7 |
2-Chloro-10-(3'-dimethylaminopropyl)-5,5-phenothiazinedioxide, hydrochloride, monohydrate
|
|
3 | 494.97 |
| 53-684-4 |
5-«alpha»-Pregnan-3-«beta»-15x-diol-20-one, TMS
|
|
3 | 386.05 |
| 56-112-5 |
5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 361.90 |
| 56-883-0 |
3-.beta.,7-.alpha.-Dihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
3 | 388.14 |
| 57-634-5 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, DMESI
|
|
3 | 341.50 |
| 57-651-6 |
Azobenzene, 2-chloro-4-nitro-4'-[2-(hydroxyethyl)(ethyl)amino]-
|
|
3 | 406.15 |
| 57-713-7 |
Trimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 340.23 |
| 58-050-2 |
3-oxy-7«alpha»-hydroxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
|
3 | 384.54 |
| 58-110-5 |
5«beta»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | 363.33 |
| 58-480-5 |
5-«alpha»-Androstan-3-«beta»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 396.41 |
| 58-508-4 |
3,17-Bis[(trimethylsilyl)oxy]-5«beta»-androstane, (3«beta»,17«beta»)-
|
18880-48-3 |
3 | 363.33 |
| 58-811-7 |
24-Nor-5.beta.-cholestane-3.alpha.,7.alpha.,25-triol, TMS
|
|
3 | 379.33 |
| 61-543-1 |
Ergostanol (24«alpha»-methyl-5«alpha»-cholestan-3«beta»-ol), TMS
|
|
3 | 368.19 |
| 64-074-9 |
2-Pyridinecarbamic acid, 5,6-diamino-4-[(diphenylmethyl)amino]-, ethyl ester
|
38359-68-1 |
3 | 478.80 |
| 64-675-2 |
(24S)-24-ethyl-5«alpha»-cholestan-3«beta»,24-diol, TMS
|
|
3 | 375.17 |
| 64-991-1 |
5-«beta»-Androstan-3-«alpha»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 396.41 |
| 66-378-0 |
2,4(1H,3H)-Pyrimidinedione, 5-[bis(2-chloroethyl)amino]-
|
|
3 | 479.15 |
| 67-066-5 |
5«beta»-Androstane-3«alpha»,17«beta»-diol,bis-TMS
|
|
3 | 363.33 |
| 67-520-0 |
(24S)-24-ethyl-5.alpha.-cholestan-3.beta.,24-diol, DMESI
|
|
3 | 364.30 |
| 67-723-5 |
Silane, [[(3«alpha»,5«beta»,20S)-pregnane-3,20-diyl]bis(oxy)]bis[trimethyl-
|
16134-56-8 |
3 | 374.21 |
| 67-819-9 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TMSi, (20-O)-TBDMSi
|
|
3 | 386.84 |
| 68-337-3 |
1,3,5(10)-Oestratriene-2-methoxy-3,17«beta»-diol, 3-TMS-17-HFB
|
|
3 | 386.39 |
| 69-084-3 |
2-keto,3-methyl-5.alpha.-androstan-17.beta.-ol, monoTBDMS
|
|
3 | 414.16 |
| 70-019-3 |
5-«beta»-Pregnan-3-«alpha»,16-«alpha»-diol-20-one, MeTMS
|
|
3 | 394.41 |
| 70-965-3 |
5-Pregnene-3«alpha»,16«alpha»,20«alpha»-triol, EO-TMS
|
|
3 | 383.22 |
| 71-557-5 |
Pregnan-20-one, 3,16-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»,16«alpha»)-
|
56247-71-3 |
3 | 394.41 |
| 72-308-0 |
Pyrido[3,4-b]pyrazine-5,7-dicarbamic acid, 2,3-diphenyl-, diethyl ester
|
16335-96-9 |
3 | 500.95 |
| 73-388-1 |
1H-1,2,3-triazole-5-carboxamide, 4-amino-, compound with picric acid
|
|
3 | 581.21 |
| 76-319-4 |
Ergosta-5,7,9(11),22-tetraen-3«beta»-ol, TMS
|
|
3 | 393.63 |
| 76-428-3 |
Pregnan-20-one, 3,21-bis[(trimethylsilyl)oxy]-, O-methyloxime, (3«alpha»,5«alpha»)-
|
57305-33-6 |
3 | 373.07 |
|
« Previous Results
Next Results »
|